Canaccord Genuity Upgrades Hologic To Buy

Analysts at Canaccord Genuity upgraded

from Hold to Buy. The price target for Hologic has been raised from $29.00 to $37.00. Hologic shares have climbed 43.53% over the past 52 weeks, while the S&P 500 index has surged 14.13% in the same period. Hologic's shares jumped 2.09% to $31.47 in pre-market trading.